U.S. Attorney General Thomas Blanch announced a historic change in marijuana classification, moving it from Schedule I to Schedule III, facilitating its medical use. However, this does not legalize recreational use nationwide.
Eli Lilly's CEO, Dave Ricks, announced the company's opposition to the White House's efforts to legislate a 'most favored nation' policy for drug pricing. This comes as the U.S. administration seeks to affirm lower drug prices in the American market.
Former British Justice Minister Crispin Blunt has confessed to possessing illegal drugs, including cannabis and amphetamines. This admission comes at a critical time as the UK grapples with significant challenges in drug policy.